Breaking
•Breaking through the 'blue wall': Trump stumps in Ohio & takes pitch to blue collar voters - WCIV•White & Case advises on Jio Platforms Limited’s record-breaking IPO - White & Case LLP•Swiss researchers develop climate adaptation tools - SWI swissinfo.ch•Climate change is becoming a global health emergency, Lancet Countdown report suggests - Open Access Government•All-rounder Saif Zaib to leave Northamptonshire after 13 years - BBC•Bournemouth in pinch-me territory as another underdog success story in English soccer - Newsday•Lincoln Riley, Ryan Day have similar backgrounds, different results - Yahoo Sports•The Lantern’s sit-down interview with Ross Bjork: state of the football team, expectations for the men’s and women’s basketball teams and stance on maintaining 36 varsity sports - The Lantern•The NHL season is one month old. Here are strong starts we believe. - Yahoo Sports•Browns using Steelers' iconic 'Renegade' hype song at practice - Yahoo Sports•Iran’s Revolutionary Guards say three oil tankers hit mines in Strait of Hormuz - Arab News•Saudi Arabia leads Middle East tourist arrivals to Indonesia - Arab News•FCDO issues travel disruption warning for 16 countries as Middle East remains ‘unpredictable’ - Yahoo News UK•South Africa chooses Durban as its preferred city to host 2036 or 2040 Olympics - Yahoo Sports•South African police seek court ban on anti-immigration marches - wdtimes.com•Putin woos African leaders at a Moscow summit aimed at expanding Russia-Africa ties - Seattle Post-Intelligencer•European Central Bank President Christine Lagarde will resign Feb. 7, nine months early - myMotherLode.com•Russia strikes Dnipro train station in central Ukraine, killing 13 - AppleValleyNewsNow.com•‘Paddington: The Musical’ Extends West End Run Due to “Unprecedented Demand”•‘Between Us’ Review: Estranged Teenagers Process Past Tragedy Through High School Theater in Fitfully Ambitious Japanese Drama•Breaking through the 'blue wall': Trump stumps in Ohio & takes pitch to blue collar voters - WCIV•White & Case advises on Jio Platforms Limited’s record-breaking IPO - White & Case LLP•Swiss researchers develop climate adaptation tools - SWI swissinfo.ch•Climate change is becoming a global health emergency, Lancet Countdown report suggests - Open Access Government•All-rounder Saif Zaib to leave Northamptonshire after 13 years - BBC•Bournemouth in pinch-me territory as another underdog success story in English soccer - Newsday•Lincoln Riley, Ryan Day have similar backgrounds, different results - Yahoo Sports•The Lantern’s sit-down interview with Ross Bjork: state of the football team, expectations for the men’s and women’s basketball teams and stance on maintaining 36 varsity sports - The Lantern•The NHL season is one month old. Here are strong starts we believe. - Yahoo Sports•Browns using Steelers' iconic 'Renegade' hype song at practice - Yahoo Sports•Iran’s Revolutionary Guards say three oil tankers hit mines in Strait of Hormuz - Arab News•Saudi Arabia leads Middle East tourist arrivals to Indonesia - Arab News•FCDO issues travel disruption warning for 16 countries as Middle East remains ‘unpredictable’ - Yahoo News UK•South Africa chooses Durban as its preferred city to host 2036 or 2040 Olympics - Yahoo Sports•South African police seek court ban on anti-immigration marches - wdtimes.com•Putin woos African leaders at a Moscow summit aimed at expanding Russia-Africa ties - Seattle Post-Intelligencer•European Central Bank President Christine Lagarde will resign Feb. 7, nine months early - myMotherLode.com•Russia strikes Dnipro train station in central Ukraine, killing 13 - AppleValleyNewsNow.com•‘Paddington: The Musical’ Extends West End Run Due to “Unprecedented Demand”•‘Between Us’ Review: Estranged Teenagers Process Past Tragedy Through High School Theater in Fitfully Ambitious Japanese Drama
TheNewsPulse.pro
Home/business/clinical trials/diseases
business

Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand

Confidence82·developingImportance88NP-EVT-20261029-A43471F

Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.

Read the original at the primary source
Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand
10/29/2026, 10:56:02 AM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · naturepulse · travelerpulse

Discussion

ChatsPulse · 0 threads

No discussion yet. Sign in and start the first thread —